A case study of pooled-studies publications indicated potential for both valuable information and bias
- PMID: 23850407
- DOI: 10.1016/j.jclinepi.2013.05.002
A case study of pooled-studies publications indicated potential for both valuable information and bias
Abstract
Objectives: Pooled-studies publications (PSPs) present statistical analyses of multiple randomized controlled trials without a systematic literature search or critical appraisal. We explored the characteristics of PSPs and their potential impact on a systematic review (SR).
Study design and setting: We systematically evaluated PSPs excluded from an SR of second-generation antidepressants. We analyzed their basic characteristics, risk of bias, and the effect of new data on review conclusions.
Results: We identified 57 PSPs containing a median of five trials (range, 2-11) and 1,233 patients (range, 117-2,919). Ninety-six percent of PSPs were industry funded, and 49% of PSPs contained unpublished data. The median number of citations for PSPs was 29 (range, 0-549). Only 7% planned pooling a priori, and 19% combined trials with identical protocols. Fifty-nine percent of PSPs eligible for general efficacy provided no new data. For some subgroups and accompanying symptoms (e.g., anxiety, insomnia, melancholia, fatigue, sex, and race), more than 30% of PSPs presented entirely new data or data that could alter the strength of the evidence available in the SR.
Conclusion: In this case study, PSPs provided new information on subgroups and secondary outcomes; however, guidance for reviewers and development of a system to assess their susceptibility to bias are required.
Keywords: Antidepressants; Bias; Depression; Pooling; Subgroups; Systematic review.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials.Psychol Med. 2019 Sep;49(12):2020-2026. doi: 10.1017/S0033291718002805. Epub 2018 Sep 28. Psychol Med. 2019. PMID: 30261934 Free PMC article.
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
-
Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.JAMA Psychiatry. 2015 May;72(5):500-10. doi: 10.1001/jamapsychiatry.2015.15. JAMA Psychiatry. 2015. PMID: 25806940
-
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.BMJ. 2012 Jan 3;344:d7202. doi: 10.1136/bmj.d7202. BMJ. 2012. PMID: 22214754
Cited by
-
Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials.Psychol Med. 2019 Sep;49(12):2020-2026. doi: 10.1017/S0033291718002805. Epub 2018 Sep 28. Psychol Med. 2019. PMID: 30261934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
